期刊文献+
共找到133篇文章
< 1 2 7 >
每页显示 20 50 100
Cancer-associated fibroblasts in hepatocellular carcinoma 被引量:26
1
作者 Norio Kubo Kenichiro Araki +1 位作者 Hiroyuki Kuwano Ken Shirabe 《World Journal of Gastroenterology》 SCIE CAS 2016年第30期6841-6850,共10页
The hepatic stellate cells in the liver are stimulated sustainably by chronic injury of the hepatocytes, activating myofibroblasts, which produce abundant collagen. Myofibroblasts are the major source of extracellular... The hepatic stellate cells in the liver are stimulated sustainably by chronic injury of the hepatocytes, activating myofibroblasts, which produce abundant collagen. Myofibroblasts are the major source of extracellular proteins during fibrogenesis, and may directly, or secreted products, contribute to carcinogenesis and tumor progression. Cancer-associated fibroblasts(CAFs) are one of the components of the tumor microenvironment that promote the proliferation and invasion of cancer cells by secreting various growth factors and cytokines. CAFs crosstalk with cancer cells stimulates tumor progression by creating a favorable microenvironment for progression, invasion, and metastasis through the epithelial-mesenchymal transition. Basic studies on CAFs have advanced, and the role of CAFs in tumors has been elucidated. In particular, for hepatocellular carcinoma, carcinogenesis from cirrhosis is a known fact, and participation of CAFs in carcinogenesis is supported. In this review, we discuss the current literature on the role of CAFs and CAF-related signaling in carcinogenesis, crosstalk with cancer cells, immunosuppressive effects, angiogenesis, therapeutic targets, and resistance to chemotherapy. The role of CAFs is important in cancer initiation and progression. CAF-targeted therapy may be effective for suppression not only of fibrosis but also cancer progression. 展开更多
关键词 Cancer associated fibroblast Hepatic stellate cell Hepatocellular carcinoma IMMUNOSUPPRESSION therapeutic target
下载PDF
胰腺实性假乳头状瘤诊断与治疗现状和进展 被引量:10
2
作者 刘征涛 郭成祥 +2 位作者 余健 白雪莉 梁廷波 《中华消化外科杂志》 CAS CSCD 北大核心 2020年第4期444-448,共5页
胰腺实性假乳头状瘤(SPN)是一种少见的胰腺低度恶性肿瘤。外科手术切除是其首选治疗方式,预后好,极少发生复发或转移,患者5年生存率约为95%。随着影像学和病理学诊断技术的进步,SPN的检出率逐步提高,但其发病机制尚不清楚;同时,该病在... 胰腺实性假乳头状瘤(SPN)是一种少见的胰腺低度恶性肿瘤。外科手术切除是其首选治疗方式,预后好,极少发生复发或转移,患者5年生存率约为95%。随着影像学和病理学诊断技术的进步,SPN的检出率逐步提高,但其发病机制尚不清楚;同时,该病在诊断标准、治疗策略等方面也缺乏规范化标准。笔者查阅相关文献,结合团队治疗SPN的临床经验,总结SPN的诊断与治疗现状和进展,旨在加深临床医师对SPN的认识,提高该病术前诊断率,促进其规范化治疗,最终使患者获得最大受益。 展开更多
关键词 胰腺肿瘤 胰腺实性假乳头状瘤 发病机制 诊断 治疗 进展
原文传递
拉米夫定联合聚乙二醇干扰素初始和再治疗慢性乙型肝炎合并脂肪肝疗效观察 被引量:10
3
作者 许俊 黄敏 《实用肝脏病杂志》 CAS 2016年第2期210-211,共2页
目的分析应用拉米夫定联合干扰素治疗慢性乙型肝炎合并脂肪肝患者的疗效。方法随机纳入65例慢性乙型肝炎合并非酒精性脂肪性肝病(NAFLD)初治和52例曾接受过核苷类药物治疗失败的慢性乙型肝炎合并NAFLD患者,给予拉米夫定联合聚乙二醇干... 目的分析应用拉米夫定联合干扰素治疗慢性乙型肝炎合并脂肪肝患者的疗效。方法随机纳入65例慢性乙型肝炎合并非酒精性脂肪性肝病(NAFLD)初治和52例曾接受过核苷类药物治疗失败的慢性乙型肝炎合并NAFLD患者,给予拉米夫定联合聚乙二醇干扰素α-2a(Peg-IFNα-2a)治疗48 w。采用荧光定量PCR法检测血清HBV DNA,采用微粒子酶免分析法检测血清HBV标志物。使用B超检查诊断脂肪肝。结果在治疗48 w时,初治组完全应答率为47.7%,而再治疗组为28.8%,差异显著(P<0.05);在治疗24 w时,初治组患者血清HBV DNA低于不可检测水平发生率为41.5%,显著高于再治组的23.1%(P<0.05),在治疗第48 w时,达到86.2%,也显著高于再治组的59.6%(P<0.05);在治疗24 w时,两组血清HBe Ag/HBe Ab转换率无明显差别,而在治疗48 w时,初治组HBe Ag/HBe Ab血清转换率明显高于再治疗组(72.3%对63.1%,P<0.05);在治疗48 w时,两组患者脂肪肝的改善率无明显差异(46.2%对50.0%,P>0.05)。结论核苷类药物与干扰素联合治疗慢性乙型肝炎合并脂肪肝患者疗效确切,在初治患者疗效更明显。 展开更多
关键词 慢性乙型肝炎 脂肪肝 拉米夫定 Α-干扰素 治疗
下载PDF
补肾调经法治疗不孕不育症96例的临床研究 被引量:9
4
作者 路臻 王宗繁 《中医临床研究》 2014年第7期44-44,46,共2页
不孕不育症是近年来妇产科门诊发病率较高的疾病,主要原因为妇科炎症、人工流产手术后月经不调等所致的排卵异常、卵子发育异常造成的不孕不育症。中医中药口服加经络疗法(穴位注射法)治疗不孕不育症,效果显著。
关键词 不孕不育症 中医中药口服 经络疗法(穴位注射法) MERIDIAN therapy(hvacupoint-injection therap)
下载PDF
肝血管瘤动脉造影诊断与栓塞治疗 被引量:7
5
作者 董汇秋 胡大为 +1 位作者 李桂平 王春华 《临床肝胆病杂志》 CAS 北大核心 2004年第4期248-250,共3页
为了探讨肝血管瘤(CHL)的肝动脉造影诊断及特异性鉴别诊断征象,总结栓塞治疗效果,寻求理想栓塞方法,回顾分析了25例CHL选择性肝动脉造影的表现与鉴别诊断征象,观察平阳霉素(PYM)超液态碘化油乳剂栓塞治疗的效果,随访6-48个月。CHL典型... 为了探讨肝血管瘤(CHL)的肝动脉造影诊断及特异性鉴别诊断征象,总结栓塞治疗效果,寻求理想栓塞方法,回顾分析了25例CHL选择性肝动脉造影的表现与鉴别诊断征象,观察平阳霉素(PYM)超液态碘化油乳剂栓塞治疗的效果,随访6-48个月。CHL典型的瘤体显影形态,造影剂染色时间的特点,可与肝癌鉴别,动-静脉瘘的出现作为鉴别依据缺乏特异性;25例栓塞治疗,其中1次栓塞18例,2次栓塞7例,瘤体均缩小达50%以上,临床有效率达100%,无严重并发症发生。选择性肝动脉造影是诊断肝血管瘤较理想的方法,介入栓塞治疗应作为首选方法推广应用。 展开更多
关键词 肝血管瘤 肝动脉造影 诊断 肝动脉栓塞 介入治疗 鉴别诊断 平阳霉素
下载PDF
Diagnosis and treatment of fungal infection after liver transplantation 被引量:4
6
作者 SHI Xian-jie LU Shao-cheng HE Lei LU Fang LIANG Yu-rong LUO Ying JI Wen-bin ZHAO Zhi-ming 《Chinese Medical Journal》 SCIE CAS CSCD 2011年第7期1015-1017,共3页
Background Liver transplantation is the most effective treatment for end-stage liver diseases; however, infections after transplantation can seriously affect the patient's health. The aim of this research was to inve... Background Liver transplantation is the most effective treatment for end-stage liver diseases; however, infections after transplantation can seriously affect the patient's health. The aim of this research was to investigate the diagnosis and treatment of fungal infection following liver transplantation. 展开更多
关键词 liver transplantation MYCOSES DIAGNOSIS therap fungal infection
原文传递
Azathioprine is essential following cyclosporine for patients with steroid-refractory ulcerative colitis 被引量:3
7
作者 Nobuyuki Miyake Takafumi Ando +12 位作者 Kazuhiro Ishiguro Osamu Maeda Osamu Watanabe Yutaka Hirayama Keiko Maeda Kazuhiro Morise Masanobu Matsushita Kazuhiro Furukawa Kohei Funasaka Masanao Nakamura Ryoji Miyahara Naoki Ohmiya Hidemi Goto 《World Journal of Gastroenterology》 SCIE CAS 2015年第1期254-261,共8页
AIM: To evaluate long-term prognosis following cyclosporine treatment by examining the rate of surgery avoidance among cyclosporine responders.METHODS: We retrospectively reviewed clinical records for 29 patients diag... AIM: To evaluate long-term prognosis following cyclosporine treatment by examining the rate of surgery avoidance among cyclosporine responders.METHODS: We retrospectively reviewed clinical records for 29 patients diagnosed with severe steroid-refractory ulcerative colitis in our hospital from August 1997 to August 2008 and treated with cyclosporine by continuous intravenous infusion.All patients were treated with intravenous corticosteroids for more than 5 d prior to cyclosporine therapy.Administration was continued for up to 21 d under serum monitoring to maintain cyclosporine levels between 400 and 600 ng/mL.Clinical activity was assessed before and after cyclosporine therapy using the clinical activity index score,with a reduction of ≥ 5 considered to indicate a response.Among responders,we defined cases not requiring surgery for more than 5 years as exhibiting long-term efficacy of cyclosporine.Factors considered to be possibly predictive of long-term efficacy of cyclosporine were sex,age,disease duration,clinical activity index score,C-reactive protein level,hemoglobin level,disease extent,endoscopic findings,and clinical course.RESULTS: Cyclosporine was not discontinued due to side effects in any patient.Nineteen(65.5%) of 29 patients were considered responders.A statistically significant(P = 0.004) inverseas sociation wa s observed between an endoscopic finding of "mucosal bleeding" and responsive cases.Fifteen(9 males,6 females) of these 19 patients were followed for 5 years or more,of whom 9(60%) exhibited long-termefficacy of cyclosporine.Of the 10 non-responders,9(90%) underwent surgery within 6 mo of cyclosporine therapy.None of the following factors had a significant impact on the long-term efficacy of cyclosporine: sex,age,duration of disease,clinical activity index score,C-reactive protein level,hemoglobin level,extent of disease,endoscopic findings,or clinical course.In contrast,a significant association was observed for maintenance therapy with azathioprine after cyclosporine therapy(P = 0.0014 展开更多
关键词 ULCERATIVE COLITIS CYCLOSPORINE Maintenance therap
下载PDF
Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer 被引量:5
8
作者 Atsuya Takeda Naoko Sanuki Etsuo Kunieda 《World Journal of Gastroenterology》 SCIE CAS 2014年第15期4220-4229,共10页
Systemic chemotherapy has enabled prolongation of survival in patients with stage IV colorectal cancer. This has subsequently increased the relative significance of local therapy for patients with oligometastases beca... Systemic chemotherapy has enabled prolongation of survival in patients with stage IV colorectal cancer. This has subsequently increased the relative significance of local therapy for patients with oligometastases because they can be cured by removal of oligometastatic lesions. One of the most frequently reported tumor histologies for oligometastases is colorectal cancer. Resection is the standard therapy in most settings of oligometastases. Recently, studies have shown that stereotactic body radiotherapy (SBRT) may become a treatment option that provides high local control with minimal morbidity. Two-year local control rates following SBRT for hepatic and pulmonary oligometastases are almost over 80% and are even higher for patients treated with high-dose regimens. The indications of SBRT for other metastatic sites or conditions include isolated lymph nodes, spinal and adrenal metastasis, and post-surgical pelvic recurrence. Many retrospective studies have indicated that SBRT for various lesions results in good outcomes with low morbidity, both in the curative and palliative setting. However, few reports with a high level of evidence have indicated the efficacy of SBRT compared to standard therapy. Hereafter, the optimal indication of SBRT needs to be prospectively investigated to obtain convincing evidence. 展开更多
关键词 Oligometastasis Colorectal cancer Radiation therapy Stereotactic ablation body radiation therapy Local therapy
下载PDF
Simultaneous elimination of cancer stem cells and bulk cancer cells by cationic-lipid-assisted nanoparticles for cancer therapy 被引量:2
9
作者 Kaige Chen Song Shen +3 位作者 Gui Zhao Zhiting Cao Xianzhu Yang Jun Wang 《Nano Research》 SCIE EI CAS CSCD 2018年第8期4183-4198,共16页
Convincing evidence indicates that the existence of cancer stem cells (CSCs) within malignant tumors is mostly responsible for the failure of chemotherapy. Therefore, instead of merely targeting bulk cancer cells, s... Convincing evidence indicates that the existence of cancer stem cells (CSCs) within malignant tumors is mostly responsible for the failure of chemotherapy. Therefore, instead of merely targeting bulk cancer cells, simultaneous elimin- ation of both CSCs and bulk cancer cells is necessary to improve therapeutic outcomes. Herein, we designed cationic-lipid-assisted nanopartides DTXLNPsRNA for simultaneous encapsulation of the conventional chemotherapeutic agent docetaxel (DTXL) and small interfering RNA (siRNA) targeting BMI-1 (siBMI-1). We confirmed that nanopartides vrxLNPsiBMI-l effectively deliver both therapeutic agents into CSCs and bulk cancer cells. The bulk cancer cells were effectively killed by the DTXL encapsulated in DVXL NPsiBMI-1. In breast CSCs, BMI-1 expression was significantly downregulated by DVXLNpsiBMI-1; consequently, the sternness was reduced and chemosensitivity of CSCs to DTXL was enhanced, resulting in the elimination of CSCs. Therefore, via DTXLNPsiBMI-1, the combination of siBMI-1 and DTXL completely inhibited tumor growth and prevented a relapse by synergistic kiUing of CSCs and bulk cancer cells in a murine model of an MDA-MB-231 orthotropic tumor. 展开更多
关键词 anti-cancer stem cells(CSCs) therap LBMI-1 combination therapy small interfering RNA(siRNA) therapy CO-DELIVERY
原文传递
Peptide-assembled siRNA nanomicelles confine MnOx-loaded silicages for synergistic chemical and gene-regulated cancer therapy
10
作者 Jingjing Li Juanjuan Wei +4 位作者 Yixuan Gao Qi Zhao Jianghui Sun Jin Ouyang Na Na 《Chinese Chemical Letters》 SCIE CAS CSCD 2023年第4期453-458,共6页
Chemodynamic therapy(CDT) is a promising therapeutic approach for in situ cancer treatment, but it is still hindered by inefficient single-modality treatment and the weak targeted delivery of reagents into mitochondri... Chemodynamic therapy(CDT) is a promising therapeutic approach for in situ cancer treatment, but it is still hindered by inefficient single-modality treatment and the weak targeted delivery of reagents into mitochondria(the main site of intracellular ROS production). Herein, to obtain a multimodal strategy,peptide-assembled si RNA nanomicelles were prepared to confine ultrasmall MnOxin small silica cages(silicages), which is convenient for synergistic chemical and gene-regulated cancer therapy. Given the free energy and versatility of small silicages, as well as the excellent Fenton-like activity of ultrasmall MnOx,MnOx-inside-loaded silicages(10 nm) were prepared for CDT delivery to mitochondria. Subsequently, to obtain a synergistic CDT and gene silencing treatment, the peptide-mediated assembly of si RNA and MnOx-loaded silicages were employed to obtain silicage@MnOx-si RNA nanomicelles(SMS NMs). After multiple modifications, sequential cancer cell-targeted delivery, GSH-controlled reagent release of si RNA and mitochondria-targeted delivery of MnOx-loaded silicages were successfully achieved. Finally, by both in vitro and in vivo experiments, SMS NMs were confirmed to be effective for synergistic chemical and gene-regulated cancer therapy. Our findings expand the applications of silicages and initiate the development of multimodal CDT. 展开更多
关键词 Peptide-assembled siRNA nanomicelles MnOx-loaded silicages GSH-stimulated release Mitochondria-targeted delivery Cancer therap
原文传递
针刺配合痹痛散外敷治疗急性期中央型腰椎间盘突出症疗效观察 被引量:3
11
作者 庄子齐 江钢辉 《新中医》 CAS 北大核心 2002年第3期47-48,共2页
目的:观察针刺特定穴配合痹痛散外敷治疗急性期中央型腰椎间盘突出症临床疗效。方法:采用针刺外丘、侠溪、金门、委中、委阳等特定穴、阿是穴,配合自制痹痛散外敷阿是穴、腰阳关、大肠俞、关元俞、环跳、阳陵泉等穴位,治疗急性期腰椎间... 目的:观察针刺特定穴配合痹痛散外敷治疗急性期中央型腰椎间盘突出症临床疗效。方法:采用针刺外丘、侠溪、金门、委中、委阳等特定穴、阿是穴,配合自制痹痛散外敷阿是穴、腰阳关、大肠俞、关元俞、环跳、阳陵泉等穴位,治疗急性期腰椎间盘突出症33例,并随机选择30例以常规针刺治疗作对照。结果:治疗组总有效率87.9%,对照组总有效率66.7%,经Ridit分析,t检验,2组总有效率差异均有显著性意义。结论;治疗组疗效优于对照组,既能提高疗效,又能缩短疗程,其作用机理可能与消除局部神经根水肿,消除局部炎症反应,减少化学致痛物质,促使突出髓核吸收,促进局部血运,解除神经压迫有关。 展开更多
关键词 急性期中央型腰椎间盘突出症 针刺疗法 痹痛散 中药外敷 治疗 疗效观察
下载PDF
Influence of night duty on endoscopic therapy for bile duct stones 被引量:1
12
作者 Mitsuru Sugimoto Tadayuki Takagi +9 位作者 Rei Suzuki Naoki Konno Hiroyuki Asama Ko Watanabe Jun Nakamura Hitomi Kikuchi Yuichi Waragai Mika Takasumi Takuto Hikichi Hiromasa Ohira 《World Journal of Gastroenterology》 SCIE CAS 2016年第42期9387-9393,共7页
AIM To examine the influence of night duty(ND) on endoscopic therapy for biliary duct stones.METHODS The subjects consisted of 133 patients who received initial endoscopic therapy for biliary duct stones performed by ... AIM To examine the influence of night duty(ND) on endoscopic therapy for biliary duct stones.METHODS The subjects consisted of 133 patients who received initial endoscopic therapy for biliary duct stones performed by eight endoscopists after they had been on(ND group, n = 34 patients) or not [day duty(DD) group, n = 99 patients]. Patient characteristics(age, gender, history of abdominal surgery, transverse diameter of the largest stone, number of stones), years of experience of the endoscopists, endoscopic procedures [sphincterotomy, papillary balloon dilation(EPBD), papillary large balloon dilation(EPLBD)], and outcomes of initial endoscopy(procedure time; rate of stone removal by the first endoscopist; proceduresuccess rate by the first endoscopist: removal of stones or endoscopic retrograde biliary drainage; rate of final stone removal; final procedure success rate; complications; hospitalization after the procedure) were compared retrospectively between the two groups. History of abdominal surgery and treatment outcomes were also compared between the groups for each of the four endoscopists who performed most of the procedures in the ND group.RESULTS There were no significant differences regarding the number of treatments performed by each endoscopist or the years of experience between the ND and DD groups. The frequency of endoscopic retrograde cholangiopancreatography procedures did not differ significantly between the groups. There were also no significant differences regarding patient characteristics: age, gender, history of abdominal surgery(ND 7: Billroth II 4, R-Y 3; DD 18: double tract reconstruction 1, Billroth I 3, Billroth II 6, R-Y 7, duodenoduodenostomy for annular pancreas 1), transverse diameter of largest stone, and number of stones between the two groups. Among the treatment procedures, the endoscopic s p h i n c t e r o t o m y a n d E P B D r a t e s d i d n o t d i f f e r significantly between the groups. However, EPLBD was performed more frequently in the ND group [47.1%(16/34) v s 19.2% 展开更多
关键词 Night duty Endoscopic therap Bile duct stone Removal of stones Procedure time
下载PDF
应用成体干细胞临床治疗神经系统疾病——极具转换医学研究价值的领域 被引量:3
13
作者 王任直 魏俊吉 《基础医学与临床》 CSCD 北大核心 2008年第8期789-791,共3页
神经系统疾病是威胁人类生活质量的重大疾病,干细胞尤其是成体干细胞的研究推动了针对此类疾病生物治疗医学的发展。相关的基础与临床研究显示出令人欣慰的治疗前景,有望成为某些难治性中枢神经系统疾病的临床治疗手段。因此应当大力加... 神经系统疾病是威胁人类生活质量的重大疾病,干细胞尤其是成体干细胞的研究推动了针对此类疾病生物治疗医学的发展。相关的基础与临床研究显示出令人欣慰的治疗前景,有望成为某些难治性中枢神经系统疾病的临床治疗手段。因此应当大力加强基础与临床研究之间的密切协作,促进干细胞移植治疗早日进入临床,为广大神经系统疾病患者服务。转换医学是架起基础医学和临床医学的桥梁和纽带,依靠转换医学的纽带作用将会促进这一领域的快速发展,具有重要的研究价值。 展开更多
关键词 神经系统疾病 成体干细胞 细胞移植 转换医学 治疗学
下载PDF
白芨微球与无水乙醇行兔门静脉栓塞的实验研究 被引量:3
14
作者 万智勇 冯敢生 +3 位作者 梁惠民 郑传胜 张贵祥 缪竟陶 《临床放射学杂志》 CSCD 北大核心 2004年第10期908-912,共5页
目的 探讨门静脉栓塞的安全范围及白芨微球作为门静脉栓塞剂的可行性与有效性。材料与方法 新西兰大白兔 30只 ,随机分为两组 ,分别以白芨微球和无水乙醇行兔门静脉不同分支栓塞治疗 ;栓塞后行连续随访2 8d ,定期复查肝功能、CT、门... 目的 探讨门静脉栓塞的安全范围及白芨微球作为门静脉栓塞剂的可行性与有效性。材料与方法 新西兰大白兔 30只 ,随机分为两组 ,分别以白芨微球和无水乙醇行兔门静脉不同分支栓塞治疗 ;栓塞后行连续随访2 8d ,定期复查肝功能、CT、门静脉造影及动物处死后组织病理检查等 ,并将所获的数据行统计学处理。结果 术后丙氨酸转氨酶 (ALT)、天冬氨酸转氨酶 (AST)变化较明显 ,术后第 1d开始增高 ,术后 5d达到最高峰 ,白芨微球组显著高于无水乙醇组 (P <0 .0 5 ) ,但两组均于栓塞后 14d逐步恢复正常。栓塞部位比较 :两组均以右上支加左内支栓塞小组增高最为明显 ,且均有 1只兔于术后 14d死亡。 2种栓塞剂均可导致门静脉段及段以下分支完全性、急性闭塞 ,邻近的门静脉分支未见异位栓塞 ;无水乙醇栓塞后 2 8d ,肝实质呈不规则散在液化坏死 ,部分栓塞的门静脉出现再通现象 ;而白芨微球栓塞后 ,肝实质呈大片状气化坏死 ,未见栓塞区门静脉再通 ;两组术后再通率与不全坏死率有显著性差异 (P <0 .0 5 )。结论 门静脉栓塞的安全性与栓塞范围密切相关 ,其安全范围应小于或等于 3个段 ;白芨微球可作为一种末梢性门静脉栓塞剂 ,其安全性与无水乙醇相似 ,但栓塞效果佳 ,值得进一步临床应用与推广。 展开更多
关键词 门静脉栓塞 白芨 门静脉 无水乙醇 微球 术后 坏死 材料
下载PDF
Postsurgical radiation therapy for gastric carcinosarcoma with c-kit expression: A case report
15
作者 Takeshi Gohongi Hiroyuki Iida +2 位作者 Naoto Gunji Kazuo Orii Takesaburo Ogat 《World Journal of Gastroenterology》 SCIE CAS 2015年第9期2830-2835,共6页
Gastric carcinosarcomas are rare morphologically biphasic tumors, consisting of carcinoma and sarcoma components, with a poor clinical course.Here we report the case of a 70-year-old man with advanced Borrmann type Ⅲ... Gastric carcinosarcomas are rare morphologically biphasic tumors, consisting of carcinoma and sarcoma components, with a poor clinical course.Here we report the case of a 70-year-old man with advanced Borrmann type Ⅲ carcinosarcoma arising from the upper body of the stomach with extensive lymph node metastasis who underwent a total, but palliative, gastrectomy.Histology showed the tumor consisted of a biphasic structure of tubular adenocarcinoma and spindle cellsarcoma.Immunohistochemistry revealed sarcoma cells expressing c-kit(CD117) and CD34, which are criteria for gastrointestinal stromal tumors.Nine months after the surgical operation, tumor metastases had extended to the hepatohilar, retroperitoneal and mediastinal lymph nodes.Radiation therapy of 50 Gy markedly decreased the size of each of these nodes and reduced the risk of respiratory complications and jaundice.However, the patient died of respiratory failure due to bronchopneumonia with multiple lung metastases 22 mo after resection.Autopsy revealed severe necrosis in most of the lymph nodes with tumor metastases.Radiation therapy combined with gastrectomy should be considered to improve survival in patients with gastric carcinosarcomas that express c-kit. 展开更多
关键词 CD34 C-KIT GASTRIC CARCINOSARCOMA Radiation therap
下载PDF
肿瘤疫苗治疗膀胱癌进展
16
作者 杨登科 《免疫学杂志》 CAS CSCD 北大核心 2002年第B06期195-199,共5页
肿瘤疫苗免疫治疗是利用肿瘤抗原进行主动免疫来激发、增强机体的主动特异性免疫反应。肿瘤疫苗的设计 ,首先是基于对肿瘤发生免疫逃逸机理的认识。肿瘤免疫逃逸机制十分复杂 ,缺乏抗原表位、MHC表达下调以及共刺激分子或某些粘附分子... 肿瘤疫苗免疫治疗是利用肿瘤抗原进行主动免疫来激发、增强机体的主动特异性免疫反应。肿瘤疫苗的设计 ,首先是基于对肿瘤发生免疫逃逸机理的认识。肿瘤免疫逃逸机制十分复杂 ,缺乏抗原表位、MHC表达下调以及共刺激分子或某些粘附分子的缺乏等可能是其重要的机理。肿瘤疫苗策略包括基因疫苗、肽和蛋白疫苗、基因修饰的肿瘤细胞疫苗以及抗独特型抗体疫苗等。利用DC细胞荷载抗原肽或者基因修饰的肿瘤细胞等建立膀胱癌细胞疫苗 ,在体内。 展开更多
关键词 肿瘤疫苗治疗 膀胱癌 主动免疫
下载PDF
Summary overview of human gene therapy trials in the U.S.
17
作者 Nelson A.Wivel 《中国实验血液学杂志》 CAS CSCD 1997年第3期289-290,共2页
It has been approximately six and one-half yearssince the first patient was enrolled in a gene therapyclinical trial. Since that important begining, this typeof genetic intervention has grown into a worldwideinvestiga... It has been approximately six and one-half yearssince the first patient was enrolled in a gene therapyclinical trial. Since that important begining, this typeof genetic intervention has grown into a worldwideinvestigative activity involving about 2100 patients asof December 1996. Although it was initially 展开更多
关键词 OVERVIEW initially enrolled RESTRICTED FAMILIAL therap vaccine CYTOKINE DELIVER SUPPRESSOR
下载PDF
西德老黑博恩大学研讨会抗微生物治疗对消化道菌群影响
18
《中国微生态学杂志》 CAS CSCD 1989年第1期170-172,共3页
OBJECTIVES The Old Herborn University Seminar presents a series of seminars onthe microbial ecology of the intestinal tract, related areas, epithelial and other surfaces and its relevance to the medical field. The ser... OBJECTIVES The Old Herborn University Seminar presents a series of seminars onthe microbial ecology of the intestinal tract, related areas, epithelial and other surfaces and its relevance to the medical field. The series of seminars will provide successive coverage of thedeveloping knowledge of the interaction between indigenous microflora and various host organ systems in hu- 展开更多
关键词 抗微生物 SEMINAR MICROBIAL ECOLOGY coverage 博恩 indigenous therap successive SEMINAR
下载PDF
急性百草枯中毒的临床救治分析
19
作者 韩宏 《西部医学》 2009年第8期1368-1369,共2页
目的探讨急性百草枯(PQ)中毒的临床特点及治疗方法,以降低死亡率。方法对12例口服PQ中毒患者的临床资料进行回顾性分析。结果12例中2例存活,10例死亡,病死率为80.33%。结论急性PQ中毒病人的生存机会主要取决于服药量与就诊时间,及早洗... 目的探讨急性百草枯(PQ)中毒的临床特点及治疗方法,以降低死亡率。方法对12例口服PQ中毒患者的临床资料进行回顾性分析。结果12例中2例存活,10例死亡,病死率为80.33%。结论急性PQ中毒病人的生存机会主要取决于服药量与就诊时间,及早洗胃、有效导泻、适时血液灌流、早期应用抗氧化损伤药物和肾上腺皮质激素,给予器官功能支持、控制感染等综合治疗措施可降低病死率。 展开更多
关键词 百草枯中毒 预后 治疗
下载PDF
克拉霉素、甲硝唑和兰索拉唑联合治疗幽门螺杆菌感染的临床疗效观察 被引量:54
20
作者 胡品津 李瑜元 +3 位作者 陈湖 吴惠生 崔毅 黎庆宁 《中华消化杂志》 CAS CSCD 北大核心 1997年第4期204-206,共3页
目的:本文报道克拉霉素与甲硝唑及兰索拉唑联合应用治疗HP阳性的十二指肠溃疡。方法:59例符合条件的病人随机分成两个治疗组,其中30例口服充拉霉素250mg,甲硝唑400mg,兰索拉唑30mg。另一组29例口服克拉霉素... 目的:本文报道克拉霉素与甲硝唑及兰索拉唑联合应用治疗HP阳性的十二指肠溃疡。方法:59例符合条件的病人随机分成两个治疗组,其中30例口服充拉霉素250mg,甲硝唑400mg,兰索拉唑30mg。另一组29例口服克拉霉素500mg,甲硝唑400mg.兰索拉唑30mg,用法均为每日2次,疗程1周,继而口服兰索拉唑30mg,每日1次,共1周。疗程结束后1个月复查胃镜。结果:克拉霉素1000mg组HP根除率及溃疡愈合率分别为93.1%及89.7%,稍高于克拉霉素500mg组的76.7%及80.0%,但差异无显著性(P>0.05)。体外检测。克拉霉素HP耐药发生率仅4.8%,而甲硝唑HP耐药发生率则达33.3%,且甲硝唑耐药对HP根除率有较大影响。两组病人副反应总发生率为15.3%,克拉霉素两个剂量组间副反应发生率无明显差别,未发现严重副反应。病人依从性良好。结论:克拉霉素与甲硝唑及兰索拉唑合用1周疗法有较理想的溃疡愈合率与HP根除率;克拉霉素用量以每日1000mg为佳。 展开更多
关键词 幽门螺杆菌 十二指肠溃疡 药物疗法 克拉霉素
原文传递
上一页 1 2 7 下一页 到第
使用帮助 返回顶部